What are the recommended tests and treatment options for diagnosing HIV?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Tests for HIV Diagnosis

The recommended initial HIV screening test is a combination HIV antibody/p24 antigen test, which has sensitivity and specificity greater than 99.5%, followed by confirmatory testing with Western blot or immunofluorescent assay for positive results. 1, 2

HIV Testing Algorithm

Initial Screening

  • Combination HIV antibody/p24 antigen test (preferred initial screening test)

    • Detects both HIV antibodies and p24 antigen
    • Allows earlier detection of HIV infection than antibody-only tests
    • Sensitivity and specificity >99.5%
    • Results available within 1-2 days from commercial laboratories 1
  • Rapid HIV testing (alternative for immediate results)

    • Can use blood or oral fluid specimens
    • Results available in 5-40 minutes
    • Sensitivity and specificity >99.5%
    • Positive results require confirmation with conventional methods 1

Confirmatory Testing

For reactive initial screening tests:

  1. HIV-1/HIV-2 antibody differentiation immunoassay

    • Differentiates between HIV-1 and HIV-2 antibodies 2
  2. If differentiation assay is negative or indeterminate:

    • Nucleic Acid Amplification Test (NAAT) such as HIV RNA PCR
    • Rules out acute HIV infection
    • Detects virus directly rather than antibody response 2

Special Testing Considerations

For Infants and Children <18 Months

  • HIV DNA PCR testing is preferred

    • Detects HIV genetic material directly
    • Not affected by maternal antibodies
    • 93% of infected infants test positive by 14 days of age 2
  • Recommended testing schedule:

    • Initial test by 48 hours of age
    • Testing at 14 days (if available)
    • Testing at 1-2 months
    • Testing at 3-6 months 2

For Recent Exposures

  • Persons with recent known or possible HIV exposure should be tested using:

    • Rapid or laboratory-based Ag/Ab test
    • Consider adding HIV NAT (RNA test) for very recent exposures 1
  • Follow-up testing after exposure:

    • Laboratory-based Ag/Ab test AND diagnostic NAT at 4-6 weeks
    • Final HIV testing 12 weeks after exposure 1

Additional Laboratory Tests After HIV Diagnosis

Once HIV infection is confirmed, the following tests should be ordered:

  1. CD4 cell count with percentage

    • Assesses immune status and disease progression
    • Baseline for monitoring treatment response 1
  2. HIV viral load (HIV RNA level)

    • Establishes baseline viral activity
    • Helps determine need for antiretroviral therapy
    • Used to monitor response to therapy 1
  3. HIV genotype testing

    • Assesses for transmitted drug resistance
    • Guides selection of antiretroviral therapy 1
  4. Additional screening tests

    • Complete blood count with differential
    • Comprehensive metabolic panel
    • Screening for co-infections (hepatitis, tuberculosis, STIs)
    • HLA-B*5701 testing before abacavir use
    • CCR5 tropism testing if considering maraviroc 1

Recommended Screening Frequency

  • All sexually active individuals: At least once in their lifetime 1
  • High-risk populations: Every 3-12 months
    • Men who have sex with men
    • Transgender women
    • People who inject drugs
    • Persons with multiple sexual partners 1
  • Pregnant women: During each pregnancy 2

Common Pitfalls to Avoid

  1. False-negative results during "window period"

    • Antibody tests may be negative during early infection
    • Consider NAT testing for suspected acute infection 1, 3
  2. False-positive screening results

    • Can occur with autoimmune disorders or pregnancy
    • Always confirm positive screening tests 1
  3. Relying solely on antibody tests for infants <18 months

    • Maternal antibodies persist up to 18 months
    • Use virologic tests (DNA PCR) instead 2
  4. Missing acute infections

    • Fourth-generation Ag/Ab tests shorten but don't eliminate window period
    • Consider HIV RNA testing when acute infection is suspected 3
  5. Delayed linkage to care

    • Immediately connect diagnosed individuals to HIV care
    • Early treatment improves outcomes and reduces transmission 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

HIV Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Recent progress in HIV screening tests and nucleic acid tests].

Nihon rinsho. Japanese journal of clinical medicine, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.